These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21325066)

  • 1. Riluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo.
    Khan AJ; Wall B; Ahlawat S; Green C; Schiff D; Mehnert JM; Goydos JS; Chen S; Haffty BG
    Clin Cancer Res; 2011 Apr; 17(7):1807-14. PubMed ID: 21325066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole is a radio-sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells.
    Wall BA; Yu LJ; Khan A; Haffty B; Goydos JS; Chen S
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):105-9. PubMed ID: 25363352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.
    Lee HJ; Wall BA; Wangari-Talbot J; Shin SS; Rosenberg S; Chan JL; Namkoong J; Goydos JS; Chen S
    Clin Cancer Res; 2011 Nov; 17(22):7080-92. PubMed ID: 21844014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.
    Wall BA; Wangari-Talbot J; Shin SS; Schiff D; Sierra J; Yu LJ; Khan A; Haffty B; Goydos JS; Chen S
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):263-74. PubMed ID: 24330389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts.
    Baschnagel A; Russo A; Burgan WE; Carter D; Beam K; Palmieri D; Steeg PS; Tofilon P; Camphausen K
    Mol Cancer Ther; 2009 Jun; 8(6):1589-95. PubMed ID: 19509253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glutamate release inhibitor Riluzole decreases migration, invasion, and proliferation of melanoma cells.
    Le MN; Chan JL; Rosenberg SA; Nabatian AS; Merrigan KT; Cohen-Solal KA; Goydos JS
    J Invest Dermatol; 2010 Sep; 130(9):2240-9. PubMed ID: 20505744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.
    Speyer CL; Smith JS; Banda M; DeVries JA; Mekani T; Gorski DH
    Breast Cancer Res Treat; 2012 Apr; 132(2):565-73. PubMed ID: 21681448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1
    Shah R; Singh SJ; Eddy K; Filipp FV; Chen S
    Cancer Res; 2019 Apr; 79(8):1799-1809. PubMed ID: 30987979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma.
    Namkoong J; Shin SS; Lee HJ; Marín YE; Wall BA; Goydos JS; Chen S
    Cancer Res; 2007 Mar; 67(5):2298-305. PubMed ID: 17332361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma.
    Yip D; Le MN; Chan JL; Lee JH; Mehnert JA; Yudd A; Kempf J; Shih WJ; Chen S; Goydos JS
    Clin Cancer Res; 2009 Jun; 15(11):3896-902. PubMed ID: 19458050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway.
    Zhang C; Yuan XR; Li HY; Zhao ZJ; Liao YW; Wang XY; Su J; Sang SS; Liu Q
    Cell Physiol Biochem; 2015; 35(2):419-32. PubMed ID: 25613036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.
    Torres MA; Raju U; Molkentine D; Riesterer O; Milas L; Ang KK
    Invest New Drugs; 2011 Aug; 29(4):554-61. PubMed ID: 20119866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles.
    Chu SH; Karri S; Ma YB; Feng DF; Li ZQ
    Neuro Oncol; 2013 Jul; 15(7):880-90. PubMed ID: 23519742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma.
    Harada T; Harada K; Ueyama Y
    Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
    Wen Y; Li J; Koo J; Shin SS; Lin Y; Jeong BS; Mehnert JM; Chen S; Cohen-Sola KA; Goydos JS
    Cancer Res; 2014 May; 74(9):2499-509. PubMed ID: 24491800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current management of brain metastasis in melanoma: a focus on riluzole.
    Yu LJ; Wall BA; Chen S
    Expert Rev Neurother; 2015; 15(7):779-92. PubMed ID: 26092602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase.
    Chung EJ; Brown AP; Asano H; Mandler M; Burgan WE; Carter D; Camphausen K; Citrin D
    Clin Cancer Res; 2009 May; 15(9):3050-7. PubMed ID: 19366835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells,
    Khan AJ; LaCava S; Mehta M; Schiff D; Thandoni A; Jhawar S; Danish S; Haffty BG; Chen S
    Oncotarget; 2019 Apr; 10(29):2824-2834. PubMed ID: 31073373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nelfinavir induces radiation sensitization in pituitary adenoma cells.
    Zeng J; See AP; Aziz K; Thiyagarajan S; Salih T; Gajula RP; Armour M; Phallen J; Terezakis S; Kleinberg L; Redmond K; Hales RK; Salvatori R; Quinones-Hinojosa A; Tran PT; Lim M
    Cancer Biol Ther; 2011 Oct; 12(7):657-63. PubMed ID: 21811091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.